Effect of Positive End-Expiratory Pressure Titration on Venous Excess Ultrasound Score and Renal Outcomes in Patients With Acute Respiratory Distress Syndrome

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-18
SponsorFayoum University

About this trial

This study is a prospective observational cohort study conducted planned to include 40 patients with ARDS to assess the effect of different levels of PEEP titration on VExUS score and renal outcomes in patients with Acute Respiratory Distress Syndrome.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥18 years.

Diagnosis of ARDS according to the Berlin criteria.

Invasive mechanical ventilation ≥24 hours.

Requirement of PEEP ≥5 cmH₂O.

Disqualifiers

Known end-stage renal disease on chronic dialysis.

History of renal transplantation.

Pregnancy.

Known severe tricuspid regurgitation.

Trial population

patients with ARDS within 24 hours of onset and mechanically ventilated for more than 24 hours.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • VExUS score

    Other intervention

    The Venous Excess Ultrasound Score (VExUS) was calculated for each patient based on the assessment of systemic venous congestion using the following parameters: Inferior vena cava (IVC) diameter and respiratory collapsibility, Hepatic vein Doppler waveform, Portal vein Doppler pulsatility and Intrarenal venous Doppler pattern.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

VExUS score

Change in VExUS score in relation to different PEEP levels in mechanically ventilated patients with ARDS.

Time frame
3 days
2

Development of acute kidney injury (AKI)

Development of acute kidney injury (AKI), defined and staged according to the KDIGO criteria: increase in serum creatinine by ≥0.3 mg/dL within 48 hours, or ≥1.5 times baseline within 7 days, or urine output \<0.5 mL/kg/hour for 6 hours.

Time frame
3 days

Secondary outcomes

1

Requirement for renal replacement therapy (RRT) during ICU stay.

Requirement for renal replacement therapy (RRT) during ICU stay.

Time frame
3 days
2

Length of ICU stay

Length of ICU stay

Time frame
4 to 7 days
3

ICU mortality

ICU mortality during ICU Stay

Time frame
4 to 7 days

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: